(Q46021295)

18 December 2017

title

Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America. (English)

1 reference

18 December 2017

author name string

C Bantar

1

1 reference

18 December 2017

D Curcio

2

1 reference

18 December 2017

L Fernandez Canigia

3

1 reference

18 December 2017

P García

4

1 reference

18 December 2017

M Guzmán Blanco

5

1 reference

18 December 2017

A L Leal

6

1 reference

18 December 2017

Latin American Tigecycline Surveillance Group

7

1 reference

18 December 2017

publication date

1 April 2009

1 reference

18 December 2017

published in

Journal of Chemotherapy

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

144-152

1 reference

18 December 2017

Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

First class a carbapenemase isolated from enterobacteriaceae in Argentina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

A 7-year national survey on bacterial resistance in bronchoalveolar lavage from patients hospitalized in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.144

10.1179/JOC.2009.21.2.144

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017